Back
MacroGenics, Inc. 10K Form
Sell
38
MGNX
MacroGenics, Inc.
Last Price:
$1.40
Seasonality Move:
7.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | MGNX/MacroGenics, Inc. Quarterly |
| 2023-11-06 | 10Q | MGNX/MacroGenics, Inc. Quarterly |
| 2023-08-09 | 10Q | MGNX/MacroGenics, Inc. Quarterly |
| 2023-05-09 | 10Q | MGNX/MacroGenics, Inc. Quarterly |
| 2022-11-03 | 10Q | MGNX/MacroGenics, Inc. Quarterly |
| 2022-08-08 | 10Q | MGNX/MacroGenics, Inc. Quarterly |
Receive MGNX News And Ratings
See the #1 stock for the next 7 days that we like better than MGNX
MGNX Financial Statistics
Sales & Book Value
| Annual Sales: | $150M |
|---|---|
| Cash Flow: | $-30.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.06 |
| Price / Book: | 1.32 |
Profitability
| EPS (TTM): | -1.20640 |
|---|---|
| Net Income (TTM): | $-75.9M |
| Gross Margin: | $130.1M |
| Return on Equity: | -88.47% |
| Return on Assets: | -29.74% |
MacroGenics, Inc. Earnings Forecast
Key MacroGenics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for MGNX is 86.77%.
-
The Selling, General & Administrative Expenses for MGNX have been equal to 47.38% of Gross Profit Margin.
-
The Research & Development expenses have been 113.13% of Revenue.
-
The Net Earning history of MGNX is -44.66% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 7 years.
MacroGenics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MGNX |
| CUSIP: | 556099 |
| Website: | macrogenics.com |
Debt
| Debt-to-Equity Ratio: | 1.6 |
|---|---|
| Current Ratio: | 5.22 |
| Quick Ratio: | 4.85 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MGNX Technical Analysis vs Fundamental Analysis
Sell
38
MacroGenics, Inc. (MGNX)
is a Sell
Is MacroGenics, Inc. a Buy or a Sell?
-
MacroGenics, Inc. stock is rated a SellThe current MacroGenics, Inc. [MGNX] share price is $1.40. The Score for MGNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.